Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah P Blagden

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Frontiers in Oncology|July 16, 2015
Harnessing Pandemonium: The Clinical Implications of Tumor Heterogeneity in Ovarian CancerSarah P Blagden
Lancet (London, England)|February 6, 2022
Targeting MAPK in recurrent, low-grade serous ovarian cancerSarah P Blagden
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2014
The perfect arrangementSarah P Blagden
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2022
PARPs: All for One and One for All? Enhancing Diversity in Clinical TrialsShibani Nicum, Sarah P Blagden
Lancet (London, England)|January 24, 2021
A source of hope for platinum-resistant ovarian cancer?Sarah P Blagden, Shibani Nicum
Nature Reviews. Clinical Oncology|March 3, 2011
The biological and therapeutic relevance of mRNA translation in cancerSarah P Blagden, Anne E Willis
Nature Cell Biology|May 31, 2003
Polar expeditions--provisioning the centrosome for mitosisSarah P Blagden, David M Glover
Expert Review of Anticancer Therapy|May 10, 2005
Docetaxel in the management of ovarian cancerSarah P Blagden, Stan B Kaye
RNA Biology|March 2, 2021
A decade of LARP societySarah P Blagden, Mark Bayfield, Cecile Bousquet-Antonelli
Psycho-Oncology|May 21, 2019
New challenges in psycho-oncology: Using drug development methodology to improve survivorship and supportive care intervention trialsLesley Howells, Nicholas J Hulbert-Williams, Sarah P Blagden
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|July 16, 2015
Harnessing Pandemonium: The Clinical Implications of Tumor Heterogeneity in Ovarian CancerSarah P Blagden
Lancet (London, England)|February 6, 2022
Targeting MAPK in recurrent, low-grade serous ovarian cancerSarah P Blagden
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2014
The perfect arrangementSarah P Blagden
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2022
PARPs: All for One and One for All? Enhancing Diversity in Clinical TrialsShibani Nicum, Sarah P Blagden
Lancet (London, England)|January 24, 2021
A source of hope for platinum-resistant ovarian cancer?Sarah P Blagden, Shibani Nicum
Nature Reviews. Clinical Oncology|March 3, 2011
The biological and therapeutic relevance of mRNA translation in cancerSarah P Blagden, Anne E Willis
Nature Cell Biology|May 31, 2003
Polar expeditions--provisioning the centrosome for mitosisSarah P Blagden, David M Glover
Expert Review of Anticancer Therapy|May 10, 2005
Docetaxel in the management of ovarian cancerSarah P Blagden, Stan B Kaye
RNA Biology|March 2, 2021
A decade of LARP societySarah P Blagden, Mark Bayfield, Cecile Bousquet-Antonelli
Psycho-Oncology|May 21, 2019
New challenges in psycho-oncology: Using drug development methodology to improve survivorship and supportive care intervention trialsLesley Howells, Nicholas J Hulbert-Williams, Sarah P Blagden
Pageof 5